Aegon Ltd. (NYSE:AEG – Get Free Report) was the recipient of a large increase in short interest in the month of September. As of September 15th, there was short interest totalling 3,350,000 shares, an increase of 6.0% from the August 31st total of 3,160,000 shares. Approximately 0.2% of the company’s stock are sold short. Based on an average daily trading volume, of 2,270,000 shares, the days-to-cover ratio is presently 1.5 days.
Aegon Trading Down 2.7 %
Shares of NYSE:AEG opened at $6.22 on Wednesday. The firm has a fifty day moving average of $6.15 and a two-hundred day moving average of $6.23. The company has a quick ratio of 0.08, a current ratio of 0.07 and a debt-to-equity ratio of 0.52. Aegon has a 12-month low of $4.63 and a 12-month high of $6.96. The firm has a market capitalization of $13.71 billion, a P/E ratio of 6.76 and a beta of 1.07.
Aegon Cuts Dividend
The company also recently disclosed a semi-annual dividend, which was paid on Thursday, September 26th. Investors of record on Thursday, September 5th were issued a $0.1723 dividend. The ex-dividend date was Thursday, September 5th. This represents a yield of 4.9%. Aegon’s dividend payout ratio is currently 32.61%.
Institutional Trading of Aegon
Aegon Company Profile
Aegon Ltd. provides insurance, pensions, retirement, and asset management services in the United States, the Netherlands, the United Kingdom, and internationally. The company offers life, accident, property and casualty, and health insurance; annuities, retirement plans, mutual funds, and stable value solutions; residential mortgage and digital baking services; and retail and institutional investment management solutions and retirement savings vehicles and strategies.
Featured Articles
- Five stocks we like better than Aegon
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Why Lennar Stock Could Be the Best Play in the Housing Market
- What is the FTSE 100 index?
- 2 Energy Stocks Fueling the AI Datacenter Boom
- What is a Special Dividend?
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Aegon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aegon and related companies with MarketBeat.com's FREE daily email newsletter.